A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation

CT Supuran - Bioorganic & Medicinal Chemistry Letters, 2023 - Elsevier
Advances in the carbonic anhydrase (CA, EC 4.2. 1.1) research over the last three decades
are presented, with an emphasis on the deciphering of the activation mechanism, the …

An overview of novel antimicrobial carbonic anhydrase inhibitors

CT Supuran - Expert Opinion on Therapeutic Targets, 2023 - Taylor & Francis
Introduction Four different genetic families of the enzyme carbonic anhydrase (CA, EC 4.2.
1.1) are present in bacteria, α-, β-, γ-and ι-CAs. They play relevant functions related to CO2 …

Multi-and poly-pharmacology of carbonic anhydrase inhibitors

CT Supuran - Pharmacological Reviews, 2024 - Elsevier
Eight genetically distinct families of the enzyme carbonic anhydrase (CA, EC 4.2. 1.1) were
described in organisms allover the phylogenetic tree. They catalyze the hydration of CO 2 to …

Development of Penicillin-Based Carbonic Anhydrase Inhibitors Targeting Multidrug-Resistant Neisseria gonorrhoeae

A Bonardi, A Nocentini, S Giovannuzzi… - Journal of Medicinal …, 2024 - ACS Publications
The development of antibacterial drugs with new mechanisms of action is crucial in
combating the rise of antibiotic-resistant infections. Bacterial carbonic anhydrases (CAs, EC …

Management of Neisseria gonorrhoeae infection: from drug resistance to drug repurposing

L Pisano, S Giovannuzzi… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Neisseria gonorrhoeae is a common sexually transmitted disease connected
with extensive drug resistance to many antibiotics. Presently, only expanded spectrum …

Five-membered heterocyclic sulfonamides as carbonic anhydrase inhibitors

A Angeli, N Paoletti, CT Supuran - Molecules, 2023 - mdpi.com
The development of heterocyclic derivatives has progressed considerably over the past
decades, and many new carbonic anhydrase inhibitors (CAIs) fall into this field. In particular …

Drug interactions of carbonic anhydrase inhibitors and activators

CT Supuran - Expert Opinion on Drug Metabolism & Toxicology, 2024 - Taylor & Francis
ABSTRACT Introduction Carbonic anhydrases (CAs, EC 4.2. 1.1) have been established
drug targets for decades, with their inhibitors and activators possessing relevant …

Challenges for develo** bacterial CA inhibitors as novel antibiotics

CT Supuran - Enzymes, 2024 - books.google.com
Challenges for develo** bacterial CA inhibitors as novel antibiotics Page 400 CHAPTER
THIRTEEN Challenges for develo** bacterial CA inhibitors as novel antibiotics Claudiu T …

Optimization of Ethoxzolamide Analogs with Improved Pharmacokinetic Properties for In Vivo Efficacy against Neisseria gonorrhoeae

MS Youse, NS Abutaleb, A Nocentini… - Journal of Medicinal …, 2024 - ACS Publications
Drug-resistant gonorrhea is caused by the bacterial pathogen Neisseria gonorrhoeae, for
which there is no recommended oral treatment. We have demonstrated that the FDA …

Inhibition studies with simple and complex (in)organic anions of the γ-carbonic anhydrase from Mammaliicoccus (Staphylococcus) sciuri, MscCAγ

S Giovannuzzi, V De Luca, C Capasso… - Journal of Enzyme …, 2023 - Taylor & Francis
The γ-carbonic anhydrase (CA, EC 4.2. 1.1) from the pathogenic bacterium,
Mammaliicoccus (Staphylococcus) sciuri (MscCAγ) was recently cloned and purified by our …